Publication | Open Access

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

VaccinationVaccine SafetyVaccine DevelopmentImmunologyEbola VaccineVaccine EfficacyChimpanzee AdenovirusInfection ControlMedicineVaccine ResearchEpidemiology